ResMed | RMD - Debt

Stock Price
201.88
Daily Change
-0.58 -0.29%
Monthly
-10.16%
Yearly
-19.79%
Q2 Forecast
197.82

ResMed reported $847.72M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Ansell USD 805.6M 51.6M Jun/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 73.38M 3.35M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Cochlear AUD 235.7M 10.9M Jun/2025
Cooper Companies USD 2.51B 27M Sep/2025
CSL USD 11.96B 219M Dec/2024
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 118.66M 687K Dec/2025
Haemonetics USD 1.22B 5K Dec/2025
Idexx Laboratories USD 1.11B 129.39M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 485.9M 100.3M Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Philips EUR 7.81B 574M Dec/2025
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 847.72M 1.37M Dec/2025
Sigma Healthcare AUD 137.64M 1.01M Jul/2024
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Steris USD 2.05B 4.8M Dec/2025
Teleflex USD 2.73B 43.5M Dec/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025